Role of AMP-activated Protein Kinase in Cyclic AMP-dependent Lipolysis In 3T3-L1 Adipocytes*
暂无分享,去创建一个
M. Birnbaum | J. Mu | W. Yin
[1] A. Kimmel,et al. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation , 2003, The Journal of cell biology.
[2] M. Birnbaum. Lipolysis: more than just a lipase. , 2003, Journal of Cell Biology.
[3] D. Carling,et al. Functional Analysis of Mutations in the γ2 Subunit of AMP-activated Protein Kinase Associated with Cardiac Hypertrophy and Wolff-Parkinson-White Syndrome* , 2002, The Journal of Biological Chemistry.
[4] H. Lodish,et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[5] G. Shulman,et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Uchida,et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.
[7] D. Hardie,et al. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. , 2002, Diabetes.
[8] David Carling,et al. The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways* , 2002, The Journal of Biological Chemistry.
[9] Olle Ljunqvist,et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. , 2002, Diabetes.
[10] Young-Bum Kim,et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.
[11] J. Seger,et al. Novel PRKAG2 Mutation Responsible for the Genetic Syndrome of Ventricular Preexcitation and Conduction System Disease With Childhood Onset and Absence of Cardiac Hypertrophy , 2001, Circulation.
[12] M. Birnbaum,et al. ADP-Ribosylation Factor 6 Delineates Separate Pathways Used by Endothelin 1 and Insulin for Stimulating Glucose Uptake in 3T3-L1 Adipocytes , 2001, Molecular and Cellular Biology.
[13] B. Kemp,et al. An activating mutation in the γ1 subunit of the AMP‐activated protein kinase , 2001 .
[14] M. Bucan,et al. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. , 2001, Molecular cell.
[15] H. Watkins,et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. , 2001, Human molecular genetics.
[16] J. Bos,et al. Rap1 signalling: adhering to new models , 2001, Nature Reviews Molecular Cell Biology.
[17] D. Orlicky,et al. Adenovirus transduction of 3T3-L1 cells. , 2001, Journal of lipid research.
[18] C. Holm,et al. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. , 2003, Annual review of nutrition.
[19] J. Connell,et al. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. , 2000, Diabetes.
[20] C. Rogel-Gaillard,et al. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. , 2000, Science.
[21] D. Carling,et al. The regulation of AMP-activated protein kinase by phosphorylation. , 2000, The Biochemical journal.
[22] M. Birnbaum,et al. Insulin-responsive Aminopeptidase Trafficking in 3T3-L1 Adipocytes* , 2000, The Journal of Biological Chemistry.
[23] C. Londos,et al. The lipolytic stimulation of 3T3-L1 adipocytes promotes the translocation of hormone-sensitive lipase to the surfaces of lipid storage droplets. , 2000, Biochimica et biophysica acta.
[24] A. Kimmel,et al. On the Control of Lipolysis in Adipocytes , 1999, Annals of the New York Academy of Sciences.
[25] W Ogawa,et al. Insulin-Induced Phosphorylation and Activation of Cyclic Nucleotide Phosphodiesterase 3B by the Serine-Threonine Kinase Akt , 1999, Molecular and Cellular Biology.
[26] A. Saltiel,et al. Lipotransin: a novel docking protein for hormone-sensitive lipase. , 1999, Molecular cell.
[27] M. Yanagisawa,et al. ETB receptor activation leads to activation and phosphorylation of NHE3. , 1999, American journal of physiology. Cell physiology.
[28] B. Kemp,et al. Dealing with energy demand: the AMP-activated protein kinase. , 1999, Trends in biochemical sciences.
[29] S. Moule,et al. The activation of p38 MAPK by the β‐adrenergic agonist isoproterenol in rat epididymal fat cells , 1998, FEBS letters.
[30] C. Wernstedt,et al. Identification of Novel Phosphorylation Sites in Hormone-sensitive Lipase That Are Phosphorylated in Response to Isoproterenol and Govern Activation Properties in Vitro * , 1998, The Journal of Biological Chemistry.
[31] M. Carlson,et al. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.
[32] S. Hawley,et al. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.
[33] D. Carling,et al. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell‐permeable activator of AMP‐activated protein kinase , 1994, FEBS letters.
[34] A. Greenberg,et al. Mechanism of hormone-stimulated lipolysis in adipocytes: translocation of hormone-sensitive lipase to the lipid storage droplet. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] R. Colbran,et al. Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. , 1989, European journal of biochemistry.